Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways

Risk signals are characteristic of many common inflammatory diseases and can function to activate nucleotide-binding oligomerization (NLR) family pyrin domain-containing 3 (NLRP3), the innate immune signal receptor in cytoplasm. The NLRP3 inflammasome plays an important role in the development of liver fibrosis. Activated NLRP3 nucleates the assembly of inflammasomes, leading to the secretion of interleukin (IL)-1β and IL-18, the activation of caspase-1, and the initiation of the inflammatory process. Therefore, it is essential to inhibit the activation of the NLRP3 inflammasome, which plays a vital role in the immune response and in initiating inflammation. RAW 264.7 and LX-2 cells were primed with lipopolysaccharide (LPS) for 4 h and subsequently stimulated for 30 min with 5 mM of adenosine 5′-triphosphate (ATP) to activate the NLRP3 inflammasome. Thymosin beta 4 (Tβ4) was supplemented to RAW264.7 and LX-2 cells 30 min before ATP was added. As a result, we investigated the effects of Tβ4 on the NLRP3 inflammasome. Tβ4 prevented LPS-induced NLRP3 priming by inhibiting NF-kB and JNK/p38 MAPK expression and the LPS and ATP-induced production of reactive oxygen species. Moreover, Tβ4 induced autophagy by controlling autophagy markers (LC3A/B and p62) through the inhibition of the PI3K/AKT/mTOR pathway. LPS combined with ATP significantly increased thee protein expression of inflammatory mediators and NLRP3 inflammasome markers. These events were remarkably suppressed by Tβ4. In conclusion, Tβ4 attenuated NLRP3 inflammasomes by inhibiting NLRP3 inflammasome-related proteins (NLRP3, ASC, IL-1β, and caspase-1). Our results indicate that Tβ4 attenuated the NLRP3 inflammasome through multiple signaling pathway regulations in macrophage and hepatic stellate cells. Therefore, based on the above findings, it is hypothesized that Tβ4 could be a potential inflammatory therapeutic agent targeting the NLRP3 inflammasome in hepatic fibrosis regulation.

[1]  Rui Li,et al.  Macrophages produce PGE2 to promote hepatic stellate cell autophagy and liver fibrosis , 2022, Autophagy Reports.

[2]  Jianni Qi,et al.  ATRA-mediated-crosstalk between stellate cells and Kupffer cells inhibits autophagy and promotes NLRP3 activation in acute liver injury. , 2022, Cellular signalling.

[3]  Dr Lakhan Kma,et al.  The interplay of ROS and the PI3K/Akt pathway in autophagy regulation , 2021, Biotechnology and applied biochemistry.

[4]  N. Kopitar-Jerala,et al.  Interplay Between NLRP3 Inflammasome and Autophagy , 2020, Frontiers in Immunology.

[5]  Jun Quan,et al.  Exosomal miR-223 derived from natural killer cells inhibits hepatic stellate cell activation by suppressing autophagy , 2020, Molecular medicine.

[6]  U. Laufs,et al.  Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. , 2020, Journal of hepatology.

[7]  Qiaojun He,et al.  Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy. , 2020, Pharmacological research.

[8]  Yan Sun,et al.  Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF‐κB and NLRP3 inflammasome , 2020, IUBMB life.

[9]  Lungen Lu,et al.  Palmitic acid stimulates NLRP3 inflammasome activation through TLR4-NF-κB signal pathway in hepatic stellate cells , 2020, Annals of translational medicine.

[10]  Z. Yao,et al.  Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis , 2020, Cell Death & Disease.

[11]  P. Codogno,et al.  Autophagy in liver diseases: Time for translation? , 2019, Journal of hepatology.

[12]  M. Pinzani,et al.  Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. , 2019, Molecular aspects of medicine.

[13]  Ping Wei,et al.  High Glucose Suppresses Keratinocyte Migration Through the Inhibition of p38 MAPK/Autophagy Pathway , 2019, Front. Physiol..

[14]  J. Kwon,et al.  Thymosin beta 4-Induced Autophagy Increases Cholinergic Signaling in PrP (106–126)-Treated HT22 Cells , 2018, Neurotoxicity Research.

[15]  R. Ray,et al.  Hepatitis C virus–induced CCL5 secretion from macrophages activates hepatic stellate cells , 2017, Hepatology.

[16]  M. Cheng,et al.  Thymosin-β4 inhibits proliferation and induces apoptosis of hepatic stellate cells through PI3K/AKT pathway , 2017, Oncotarget.

[17]  K. Schroder,et al.  NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. , 2017, Journal of hepatology.

[18]  J. Nan,et al.  Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R‐mediated NLRP3 inflammasome activation , 2017, Pharmacological research.

[19]  Yajing Wang,et al.  Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming. , 2017, Antioxidants & redox signaling.

[20]  M. Karin,et al.  Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases. , 2016, Clinical and experimental rheumatology.

[21]  S. Akira,et al.  Regulation of inflammasomes by autophagy. , 2016, The Journal of allergy and clinical immunology.

[22]  A. Gerbes,et al.  Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model. , 2016, World journal of hepatology.

[23]  T. Wynn,et al.  Macrophages in Tissue Repair, Regeneration, and Fibrosis. , 2016, Immunity.

[24]  Mark Ellisman,et al.  NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria , 2016, Cell.

[25]  G. Storm,et al.  The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis , 2015, Scientific Reports.

[26]  A. Szabó,et al.  Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family , 2015, Mediators of inflammation.

[27]  J. Wan,et al.  Macrophage autophagy protects against liver fibrosis in mice , 2015, Autophagy.

[28]  Jieun Kim,et al.  Potential Role of Thymosin Beta 4 in Liver Fibrosis , 2015, International journal of molecular sciences.

[29]  Feng Zhang,et al.  Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway , 2015, IUBMB life.

[30]  Jeongeun Hyun,et al.  Hepatic Stellate Cells Express Thymosin Beta 4 in Chronically Damaged Liver , 2015, PloS one.

[31]  Don C Rockey,et al.  Fibrosis--a common pathway to organ injury and failure. , 2015, The New England journal of medicine.

[32]  F. Tacke,et al.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. , 2014, Hepatobiliary surgery and nutrition.

[33]  P. Codogno,et al.  Autophagy: A Multifaceted Partner in Liver Fibrosis , 2014, BioMed research international.

[34]  Yingwei Chen,et al.  Depletion of Thymosin β4 Promotes the Proliferation, Migration, and Activation of Human Hepatic Stellate Cells , 2014, Cellular Physiology and Biochemistry.

[35]  Y. Maehara,et al.  Suppression of autophagy during liver regeneration impairs energy charge and hepatocyte senescence in mice , 2014, Hepatology.

[36]  Frank Tacke,et al.  Macrophage heterogeneity in liver injury and fibrosis. , 2014, Journal of hepatology.

[37]  Alberto Mantovani,et al.  Macrophage plasticity and polarization in liver homeostasis and pathology , 2014, Hepatology.

[38]  A. Wree,et al.  NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice , 2014, Hepatology.

[39]  E. Latz,et al.  New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. , 2014, The American journal of pathology.

[40]  R. Ray,et al.  Hepatitis C Virus Induces Interleukin-1β (IL-1β)/IL-18 in Circulatory and Resident Liver Macrophages , 2013, Journal of Virology.

[41]  L. Ortiz,et al.  LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells. , 2013, American journal of respiratory cell and molecular biology.

[42]  S. Werner,et al.  Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. , 2013, Journal of hepatology.

[43]  P. Boya,et al.  Emerging regulation and functions of autophagy , 2013, Nature Cell Biology.

[44]  T. Hibi,et al.  Activated hepatic stellate cells mediate the differentiation of macrophages , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[45]  C. Hagedorn,et al.  IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease , 2013, PLoS pathogens.

[46]  H. Serve,et al.  Ubiquitination and selective autophagy , 2012, Cell Death and Differentiation.

[47]  S. Shankar,et al.  Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. , 2012, Biochemical pharmacology.

[48]  F. Tacke.  Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo , 2012, Fibrogenesis & tissue repair.

[49]  A. Sher,et al.  Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction , 2012, Nature Immunology.

[50]  Sandeep Kumar,et al.  Correction: Thymosin Beta 4 Prevents Oxidative Stress by Targeting Antioxidant and Anti-Apoptotic Genes in Cardiac Fibroblasts , 2011, PLoS ONE.

[51]  J. Tschopp,et al.  The inflammasome: an integrated view , 2011, Immunological reviews.

[52]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[53]  J. Tschopp,et al.  Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation , 2011, The Journal of Biological Chemistry.

[54]  S. Ryter,et al.  Autophagy proteins regulate innate immune response by inhibiting NALP3 inflammasome-mediated mitochondrial DNA release , 2010, Nature Immunology.

[55]  Jonathan L. Schmid-Burgk,et al.  Inflammasomes: current understanding and open questions , 2011, Cellular and Molecular Life Sciences.

[56]  M. Komatsu,et al.  Physiological significance of selective degradation of p62 by autophagy , 2010, FEBS letters.

[57]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[58]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[59]  S. Akira,et al.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production , 2008, Nature.

[60]  B. Finlay,et al.  The caspase-1 inflammasome: a pilot of innate immune responses. , 2008, Cell host & microbe.

[61]  S. Friedman,et al.  Hepatic Fibrogenesis , 2018, Sherlock's Diseases of the Liver and Biliary System.

[62]  P. Qiu,et al.  Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. , 2007, Experimental eye research.

[63]  Chieh-Yu Lin,et al.  Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction , 2006, FEBS letters.

[64]  A. Czaja,et al.  Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis , 2004, Hepatology.

[65]  J. Dranoff,et al.  Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[66]  H. Kleinman,et al.  Thymosin β4 promotes angiogenesis, wound healing, and hair follicle development , 2004, Mechanisms of Ageing and Development.

[67]  H. Kleinman,et al.  Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. , 2001, Experimental eye research.

[68]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.